feed,title,long_url,short_url
MedRxiv,"Casirivimab and Imdevimab Treatment in Seropositive, Hospitalized COVID-19 Patients With Non-neutralizing or Borderline Neutralizing Antibodies",https://medrxiv.org/cgi/content/short/2022.06.14.22276389v1?rss=1,https://bit.ly/3MXjAIG
